Risk management for disease modifying treatments.
Předmět: | |
---|---|
Zdroj: | Multiple Sclerosis Journal; Sep2013 Supplement, p252-258, 7p |
Abstrakt: | The article presents abstracts on topics related to multiple sclerosis including a comparison of therapeutic efficacy and satisfaction of German patients with relapsing remitting multiple sclerosis (RRMS), the prevalence of John Cunningham virus (JCV) antibodies in human serum and seroconversion rate, and the detection and management of glomerulonephritis, and the prediction of clinical worsening after natalizumab withdrawal. |
Databáze: | Complementary Index |
Externí odkaz: |